Literature DB >> 22416196

Comparative antifungal activity of cilofungin (LY121019) against Candida species, including evaluation of susceptibility testing method.

A H Chagla1, J H Hii, D J Hoban, A E Simor, S Ferro, E Witwicki, R Poon, D E Low.   

Abstract

The in vitro activity of cilofungin against 100 Candida species was compared with 5-flucytosine. amphotericin B and ketoconazole by two laboratories independently and in a blinded fashion using a macrotitre dilution broth method in saam-f medium. Cilofungin showed good in vitro activity against Candida albicans. Candida tropicalis and Candida glabrata (90% minimal inhibitory concentration [MIC] 3.2 μg/mL) but was inactive against other Candida species. When testing the susceptibility of cilofungin, 5-flucytosine and amphotericin B at the two centres, approximately 90% of the Candida strains had MICs differing by fourfold or less. However, when testing susceptibility of ketoconazole, only 51% of the Candida strains had MIC differences fourfold or less. MIC susceptibility testing with cilofungin, 5-flucytosine and amphotericin B in saam-f medium is reproducible.

Entities:  

Keywords:  Antifungal susceptibility testing; Candida species; Cilofungin; LY121019

Year:  1992        PMID: 22416196      PMCID: PMC3298068          DOI: 10.1155/1992/260839

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  14 in total

1.  Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents.

Authors:  M A Pfaller; S Wey; T Gerarden; A Houston; R P Wenzel
Journal:  Diagn Microbiol Infect Dis       Date:  1989 Jan-Feb       Impact factor: 2.803

2.  Evaluation of in vitro antifungal activity of LY121019.

Authors:  M Hobbs; J Perfect; D Durack
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

Review 3.  Antifungal susceptibility tests.

Authors:  J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  Cilofungin (LY121019), an antifungal agent with specific activity against Candida albicans and Candida tropicalis.

Authors:  G S Hall; C Myles; K J Pratt; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1988-09       Impact factor: 5.191

5.  In vitro susceptibilities of yeasts to a new antifungal triazole, SCH 39304: effects of test conditions and relation to in vivo efficacy.

Authors:  K A McIntyre; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1989-07       Impact factor: 5.191

6.  In vitro and in vivo anti-Candida activity and toxicology of LY121019.

Authors:  R S Gordee; D J Zeckner; L F Ellis; A L Thakkar; L C Howard
Journal:  J Antibiot (Tokyo)       Date:  1984-09       Impact factor: 2.649

7.  Susceptibility of three groups of Staphylococcus aureus to newer antimicrobial agents.

Authors:  G W Jordan; P D Hoeprich
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  A study of the antifungal activity of LY121019, a new echinocandin derivative.

Authors:  V Strippoli; F D D'Auria; N Simonetti
Journal:  Chemioterapia       Date:  1988-02

9.  Lysis of growing yeast-form cells of Candida albicans by echinocandin: a cytological study.

Authors:  A Cassone; R E Mason; D Kerridge
Journal:  Sabouraudia       Date:  1981-06

10.  Cilofungin (LY121019) inhibits Candida albicans (1-3)-beta-D-glucan synthase activity.

Authors:  C S Taft; T Stark; C P Selitrennikoff
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.